Natasha B Leighl, BSc, MMSc, MD

  • Lung cancer therapy including novel compounds and early phase trials
  • Breast cancer therapeutics including novel compounds and early phase trials
  • Health services research
  • Economics of lung cancer therapy
  • Treatment decision-making in advanced cancer, including development of patient decision aids
  • Patient-physician communication

For a list of Dr. Leighl's publications, please visit PubMed or Scopus.


Associate Professor, Department of Medicine, University of Toronto
President, Lung Cancer Canada
Chair, Working Group on Economic Analysis, National Cancer Institute of Canada Clinical Trials Group​